デフォルト表紙
市場調査レポート
商品コード
1191219

がん診断の世界市場 - 市場規模(用途別、がんタイプ別、最終用途別)、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測(2023年~2032年)

Cancer Diagnostics Market Size By Application, By Cancer Type, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 300 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
がん診断の世界市場 - 市場規模(用途別、がんタイプ別、最終用途別)、業界分析、地域の見通し、成長可能性、競合の市場シェア、予測(2023年~2032年)
出版日: 2023年01月13日
発行: Global Market Insights Inc.
ページ情報: 英文 300 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん診断市場は、がんに対する意識の高まりと、よりよい革新的な治療の提供に向けた医療支出の増加により、2032年まで大きく成長すると予測されています。

当レポートでは、世界のがん診断市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 がん診断業界の考察

  • 業界セグメンテーション
  • 業界情勢(2018年~2032年)
  • 業界に対する影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 成長可能性分析
    • 用途別
    • がんタイプ別
    • 最終用途別
  • COVID-19の影響の分析
  • 規制情勢
    • 米国
    • 欧州
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 競合情勢(2022年)

  • イントロダクション
  • 企業マトリックス分析
  • 戦略ダッシュボード

第5章 がん診断市場:用途別

  • 主な用途の動向
  • 腫瘍バイオマーカー検査
  • イメージング
    • 市場の推計と予測(2018年~2032年)
    • 超音波、放射線
    • マンモグラフィ
    • MRIスキャン
    • PETスキャン
    • CTスキャン
    • SPECT、その他
  • 生検
  • リキッドバイオプシー
  • 免疫組織化学
  • In situハイブリダイゼーション

第6章 がん診断市場:がんタイプ別

  • 主ながん種の動向
  • 膀胱がん
  • 乳がん
  • 結腸がん、直腸がん
  • 子宮内膜がん
  • 腎臓がん
  • 白血病
  • 肝肺がん
  • メラノーマ
  • 非ホジキンリンパ腫
  • 膵臓がん
  • 前立腺がん
  • 甲状腺がん
  • その他

第7章 がん診断市場:最終用途別

  • 主な最終用途の動向
  • 病院
  • 診断検査室
  • 画像診断センター
  • がん研究機関

第8章 がん診断市場:地域別

  • 主な地域の動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第9章 企業プロファイル

  • Abbott Laboratories
  • AB Sciex Pte. Ltd
  • Agilent Technologies Inc
  • Becton, Dickinson and Company
  • Biocare Medical LLC
  • Biocartis
  • BioMerieux SA
  • Bio-Rad Laboratories
  • Cancer Genetics Inc
  • GE Healthcare
  • Hologic Inc
  • Janssen Diagnostics LLC (Johnson & Johnson)
  • Leica Biosystem Nussloch GmbH (Danaher Corporation)
  • Myriad Genetics, Inc
  • Qiagen N.V
  • F-Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fischer Scientific
図表

Data Tables

  • TABLE 1. Global cancer diagnostics market, 2018 - 2022(USD Million)
  • TABLE 2. Global cancer diagnostics market, 2023 - 2032(USD Million)
  • TABLE 3. Global cancer diagnostics market, by application, 2018 - 2022(USD Million)
  • TABLE 4. Global cancer diagnostics market, by application, 2023 - 2032(USD Million)
  • TABLE 5. Global cancer diagnostics market, by cancer type, 2018 - 2022(USD Million)
  • TABLE 6. Global cancer diagnostics market, by cancer type, 2023 - 2032(USD Million)
  • TABLE 7. Global cancer diagnostics market, by end-use, 2018 - 2022(USD Million)
  • TABLE 8. Global cancer diagnostics market, by end-use, 2023 - 2032(USD Million)
  • TABLE 9. Global cancer diagnostics market, by region, 2018 - 2022(USD Million)
  • TABLE 10. Global cancer diagnostics market, by region, 2023 - 2032(USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Tumor biomarkers tests market, 2018 - 2022(USD Million)
  • TABLE 13. Tumor biomarkers tests market, 2023 - 2032(USD Million)
  • TABLE 14. Imaging market, 2018 - 2022(USD Million)
  • TABLE 15. Imaging market, 2023 - 2032(USD Million)
  • TABLE 16. Ultrasound and radiology market, 2018 - 2022(USD Million)
  • TABLE 17. Ultrasound and radiology market, 2023 - 2032(USD Million)
  • TABLE 18. Medicare reimbursement for mammography
  • TABLE 19. Mammography market, 2018 - 2022(USD Million)
  • TABLE 20. Mammography market, 2023 - 2032(USD Million)
  • TABLE 21. MRI Scan market, 2018 - 2022(USD Million)
  • TABLE 22. MRI Scan market, 2023 - 2032(USD Million)
  • TABLE 23. PET Scan market, 2018 - 2022(USD Million)
  • TABLE 24. PET Scan market, 2023 - 2032(USD Million)
  • TABLE 25. CT Scan market, 2018 - 2022(USD Million)
  • TABLE 26. CT Scan market, 2023 - 2032(USD Million)
  • TABLE 27. SPECT and others market, 2018 - 2022(USD Million)
  • TABLE 28. SPECT and others market, 2023 - 2032(USD Million)
  • TABLE 29. Biopsy market, 2018 - 2022(USD Million)
  • TABLE 30. Biopsy market, 2023 - 2032(USD Million)
  • TABLE 31. Liquid biopsy market, 2018 - 2022(USD Million)
  • TABLE 32. Liquid biopsy market, 2023 - 2032(USD Million)
  • TABLE 33. Immunohistochemistry market, 2018 - 2022(USD Million)
  • TABLE 34. Immunohistochemistry market, 2023 - 2032(USD Million)
  • TABLE 35. In situ hybridization market, 2018 - 2022(USD Million)
  • TABLE 36. In situ hybridization market, 2023 - 2032(USD Million)
  • TABLE 37. Bladder cancer market, 2018 - 2022(USD Million)
  • TABLE 38. Bladder cancer market, 2023 - 2032(USD Million)
  • TABLE 39. Breast cancer market, 2018 - 2022(USD Million)
  • TABLE 40. Breast cancer market, 2023 - 2032(USD Million)
  • TABLE 41. Colon and rectal cancer market, 2018 - 2022(USD Million)
  • TABLE 42. Colon and rectal cancer market, 2023 - 2032(USD Million)
  • TABLE 43. Endometrial cancer market, 2018 - 2022(USD Million)
  • TABLE 44. Endometrial cancer market, 2023 - 2032(USD Million)
  • TABLE 45. Kidney cancer market, 2018 - 2022(USD Million)
  • TABLE 46. Kidney cancer market, 2023 - 2032(USD Million)
  • TABLE 47. Leukemia market, 2018 - 2022(USD Million)
  • TABLE 48. Leukemia market, 2023 - 2032(USD Million)
  • TABLE 49. Liver-lung cancer market, 2018 - 2022(USD Million)
  • TABLE 50. Liver-lung cancer market, 2023 - 2032(USD Million)
  • TABLE 51. Melanoma market, 2018 - 2022(USD Million)
  • TABLE 52. Melanoma market, 2023 - 2032(USD Million)
  • TABLE 53. Non-Hodgkin lymphoma market, 2018 - 2022(USD Million)
  • TABLE 54. Non-Hodgkin lymphoma market, 2023 - 2032(USD Million)
  • TABLE 55. Pancreatic cancer market, 2018 - 2022(USD Million)
  • TABLE 56. Pancreatic cancer market, 2023 - 2032(USD Million)
  • TABLE 57. Prostate cancer market, 2018 - 2022(USD Million)
  • TABLE 58. Prostate cancer market, 2023 - 2032(USD Million)
  • TABLE 59. Thyroid cancer market, 2018 - 2022(USD Million)
  • TABLE 60. Thyroid cancer market, 2023 - 2032(USD Million)
  • TABLE 61. Others market, 2018 - 2022(USD Million)
  • TABLE 62. Others market, 2023 - 2032(USD Million)
  • TABLE 63. Hospitals market, 2018 - 2022(USD Million)
  • TABLE 64. Hospitals market, 2023 - 2032(USD Million)
  • TABLE 65. Diagnostic laboratories market, 2018 - 2022(USD Million)
  • TABLE 66. Diagnostic laboratories market, 2023 - 2032(USD Million)
  • TABLE 67. Diagnostic imaging centers market, 2018 - 2022(USD Million)
  • TABLE 68. Diagnostic imaging centers market, 2023 - 2032(USD Million)
  • TABLE 69. Cancer research institutes market, 2018 - 2022(USD Million)
  • TABLE 70. Cancer research institutes market, 2023 - 2032(USD Million)
  • TABLE 71. North America cancer diagnostics market size, by country, 2018 - 2022(USD Million)
  • TABLE 72. North America cancer diagnostics market size, by country, 2023 - 2032(USD Million)
  • TABLE 73. North America cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 74. North America cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 75. North America cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 76. North America cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 77. North America cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 78. North America cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 79. North America cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 80. North America cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 81. U.S. cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 82. U.S. cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 83. U.S. cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 84. U.S. cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 85. U.S. cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 86. U.S. cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 87. U.S. cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 88. U.S. cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 89. Canada cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 90. Canada cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 91. Canada cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 92. Canada cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 93. Canada cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 94. Canada cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 95. Canada cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 96. Canada cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 97. Europe cancer diagnostics market size, by country, 2018 - 2022(USD Million)
  • TABLE 98. Europe cancer diagnostics market size, by country, 2023 - 2032(USD Million)
  • TABLE 99. Europe cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 100. Europe cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 101. Europe cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 102. Europe cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 103. Europe cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 104. Europe cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 105. Europe cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 106. Europe cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 107. Germany cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 108. Germany cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 109. Germany cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 110. Germany cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 111. Germany cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 112. Germany cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 113. Germany cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 114. Germany cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 115. UK cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 116. UK cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 117. UK cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 118. UK cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 119. UK cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 120. UK cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 121. UK cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 122. UK cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 123. France cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 124. France cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 125. France cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 126. France cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 127. France cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 128. France cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 129. France cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 130. France cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 131. Italy cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 132. Italy cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 133. Italy cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 134. Italy cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 135. Italy cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 136. Italy cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 137. Italy cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 138. Italy cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 139. Spain cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 140. Spain cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 141. Spain cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 142. Spain cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 143. Spain cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 144. Spain cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 145. Spain cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 146. Spain cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 147. Russia cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 148. Russia cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 149. Russia cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 150. Russia cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 151. Russia cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 152. Russia cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 153. Russia cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 154. Russia cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 155. Asia Pacific cancer diagnostics market size, by country, 2018 - 2022(USD Million)
  • TABLE 156. Asia Pacific cancer diagnostics market size, by country, 2023 - 2032(USD Million)
  • TABLE 157. Asia Pacific cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 158. Asia Pacific cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 159. Asia Pacific cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 160. Asia Pacific cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 161. Asia Pacific cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 162. Asia Pacific cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 163. Asia Pacific cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 164. Asia Pacific cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 165. China cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 166. China cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 167. China cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 168. China cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 169. China cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 170. China Cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 171. China cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 172. China cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 173. India cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 174. India cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 175. India cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 176. India cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 177. India cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 178. India cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 179. India cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 180. India cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 181. Japan cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 182. Japan cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 183. Japan cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 184. Japan cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 185. Japan cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 186. Japan cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 187. Japan cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 188. Japan cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 189. Australia cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 190. Australia cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 191. Australia cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 192. Australia cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 193. Australia cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 194. Australia cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 195. Australia cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 196. Australia cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 197. Latin America cancer diagnostics market size, by country, 2018 - 2022(USD Million)
  • TABLE 198. Latin America cancer diagnostics market size, by country, 2023 - 2032(USD Million)
  • TABLE 199. Latin America cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 200. Latin America cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 201. Latin America cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 202. Latin America cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 203. Latin America cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 204. Latin America cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 205. Latin America cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 206. Latin America cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 207. Brazil cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 208. Brazil cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 209. Brazil cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 210. Brazil cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 211. Brazil cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 212. Brazil cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 213. Brazil cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 214. Brazil cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 215. Argentina cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 216. Argentina cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 217. Argentina cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 218. Argentina cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 219. Argentina cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 220. Argentina cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 221. Argentina cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 222. Argentina cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 223. Mexico cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 224. Mexico cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 225. Mexico cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 226. Mexico cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 227. Mexico cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 228. Mexico cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 229. Mexico market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 230. Mexico cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 231. MEA cancer diagnostics market size, by country, 2018 - 2022(USD Million)
  • TABLE 232. MEA cancer diagnostics market size, by country, 2023 - 2032(USD Million)
  • TABLE 233. MEA cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 234. MEA cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 235. MEA cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 236. MEA cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 237. MEA cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 238. MEA cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 239. MEA cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 240. MEA cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 241. South Africa cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 242. South Africa cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 243. South Africa cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 244. South Africa cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 245. South Africa cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 246. South Africa cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 247. South Africa cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 248. South Africa cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 249. Saudi Arabia cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 250. Saudi Arabia cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 251. Saudi Arabia cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 252. Saudi Arabia cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 253. Saudi Arabia cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 254. Saudi Arabia cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 255. Saudi Arabia cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 256. Saudi Arabia cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)
  • TABLE 257. UAE cancer diagnostics market size, by application, 2018 - 2022(USD Million)
  • TABLE 258. UAE cancer diagnostics market size, by application, 2023 - 2032(USD Million)
  • TABLE 259. UAE cancer diagnostics market size, by imaging, 2018 - 2022(USD Million)
  • TABLE 260. UAE cancer diagnostics market size, by imaging, 2023 - 2032(USD Million)
  • TABLE 261. UAE cancer diagnostics market size, by cancer type, 2018 - 2022(USD Million)
  • TABLE 262. UAE cancer diagnostics market size, by cancer type, 2023 - 2032(USD Million)
  • TABLE 263. UAE cancer diagnostics market size, by end-use, 2018 - 2022(USD Million)
  • TABLE 264. UAE cancer diagnostics market size, by end-use, 2023 - 2032(USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Cancer diagnostics industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global cancer diagnostics market, 2018 - 2032 (USD Mn)
  • FIG. 6 Growth potential analysis, by application
  • FIG. 7 Growth potential analysis, by cancer type
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Company matrix analysis
  • FIG. 10 Competitive dashboard
目次
Product Code: 2406

Cancer Diagnostics Market is anticipated to grow substantially through 2032, owing to the increasing awareness around cancer and rising healthcare expenditure for offering better and more innovative treatments. Growing chronic illnesses, high disposable incomes, and increasing infectious disease prevalence have resulted in the demand for pathological laboratories, positively influencing the cancer diagnostics industry outlook. Besides, the growing need to diagnose lump formation at nascent stages will as well add impetus to the cancer diagnostics demand.

Overall, the cancer diagnostics industry is segmented in terms of application, cancer, end-use, and region.

Based on application, the tumor biomarkers tests segment was valued at over USD 27.5 billion in 2022. The wide application of biomarkers in cancer treatment, drug development, and diagnostics is slated to impel the product demand through the coming years. Besides, biomarkers are crucial for every stage of the disease. Additionally, the effectiveness and affordability of tumor biomarker tests would stimulate the market growth curve over 2023-2032.

Considering the cancer, the breast cancer segment will register notable growth during the estimated timeframe. Increasing cases of breast cancer recorded worldwide due to unhealthy lifestyles, obesity, and reduced childbearing will bolster the segmental growth in the ensuing years. For the record, in 2022, an estimated 287,850 new cases of invasive and 51,400 new cases of non-invasive breast cancer were diagnosed in women in the U.S.

By end-use, the diagnostic laboratories segment is expected to depict more than 9.5% CAGR during the forecast timeframe. Diagnosis of a medical condition, precise readings, helping the doctor reach a conclusion, online reports, advanced equipment, and deliverance of instant results are some key factors slated to boost segmental expansion in the foreseeable future.

Regionally, the Asia Pacific cancer diagnostics market is expected to grow significantly from 2023 to 2032. The regional market growth can be attributed to the constantly surging tobacco and alcohol consumption. In addition, sedentary lifestyle and unhealthy eating habits will also serve as key factors leading to several types of cancers, owing to which there has been a rising demand for diagnostics services in developed economies. According to reliable reports, in 2020, the cancer prevalence in the APAC region was 169.1 per 1,00,000, which accounted for 49.3% of the cancer incidence globally.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Secondary
      • 1.7.1.1 Paid sources
      • 1.7.1.2 Public sources
    • 1.7.2 Primary

Chapter 2 Executive Summary

  • 2.1 Cancer diagnostics industry 360 degree synopsis, 2018-2032
    • 2.1.1 Business trends
    • 2.1.2 Application trends
    • 2.1.3 Cancer type rends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Cancer Diagnostics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of cancer globally
      • 3.3.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
      • 3.3.1.3 Growing number of diagnostic laboratories in developed countries
      • 3.3.1.4 Technology advancements in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High capital investment coupled with high costs associated with diagnostic imaging systems
      • 3.3.2.2 Risk related with high radiation exposure affecting use of CT scanner
  • 3.4 Growth potential analysis
    • 3.4.1 By application
    • 3.4.2 By cancer type
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Strategic dashboard

Chapter 5 Cancer Diagnostics Market, By Application

  • 5.1 Key application trends
  • 5.2 Tumor biomarkers tests
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Imaging
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Ultrasound and radiology
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Mammography
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 MRI scan
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 PET scan
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.6 CT scan
      • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.7 SPECT & others
      • 5.3.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Biopsy
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Liquid biopsy
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.6 Immunohistochemistry
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.7 In situ hybridization
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Cancer Diagnostics Market, By Cancer Type

  • 6.1 Key cancer type trend
  • 6.2 Bladder cancer
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Breast cancer
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Colon and rectal cancer
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Endometrial cancer
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.6 Kidney cancer
    • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.7 Leukemia
    • 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.8 Liver-lung cancer
    • 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.9 Melanoma
    • 6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.10 Non-Hodgkin lymphoma
    • 6.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.11 Pancreatic cancer
    • 6.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.12 Prostate cancer
    • 6.12.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.13 Thyroid cancer
    • 6.13.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.14 Others
    • 6.14.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Cancer Diagnostics Market, By End-use

  • 7.1 Key end-use trend
  • 7.2 Hospitals
    • 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.3 Diagnostic laboratories
    • 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.4 Diagnostic imaging centers
    • 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.5 Cancer research institutes
    • 7.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Cancer Diagnostics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 AB Sciex Pte. Ltd
  • 9.3 Agilent Technologies Inc
  • 9.4 Becton, Dickinson and Company
  • 9.5 Biocare Medical LLC
  • 9.6 Biocartis
  • 9.7 BioMerieux SA
  • 9.8 Bio-Rad Laboratories
  • 9.9 Cancer Genetics Inc
  • 9.10 GE Healthcare
  • 9.11 Hologic Inc
  • 9.12 Janssen Diagnostics LLC (Johnson & Johnson)
  • 9.13 Leica Biosystem Nussloch GmbH (Danaher Corporation)
  • 9.14 Myriad Genetics, Inc
  • 9.15 Qiagen N.V
  • 9.16 F-Hoffmann-La Roche Ltd
  • 9.17 Siemens Healthineers
  • 9.18 Sysmex Corporation
  • 9.19 Thermo Fischer Scientific